Medical research

Improving treatment for hairy cell leukemia

Patients with relapsed or refractory hairy cell leukemia who were treated with vemurafenib experienced excellent response and relapse-free survival, according to a recent clinical trial published in Blood.

Obstetrics & gynaecology

U.S. birth rates continue to fall

Continuing a decades-long trend, the percentage of American women who've ever had a child declined again in the latest figures from the U.S. Centers for Disease Control and Prevention.

page 3 from 14